secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001193125-24-004911
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Korro Bio updates corporate presentation for J.P. Morgan Healthcare Conference; no specific financial data disclosed
--------------------------------------------------------------------------------

- Corporate presentation updated as of January 9, 2024, for use in investor meetings.
- Presentation filed as Exhibit 99.1 to Form 8-K; no material changes to financial outlook or pipeline disclosed in filing.
- Event is a routine update for a healthcare conference; no new guidance, partnerships, or regulatory milestones announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312524004911/0001193125-24-004911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312524004911/d466614d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-004911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer